BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 28562518)

  • 21. Glycosylated ferritin as an improved marker for post-transfusion iron overload.
    Ishihara A; Yamauchi T; Ikeda K; Fukuyoshi Y; Yokoyama T; Yonemura Y; Uchiba M; Matsui H
    Int J Hematol; 2021 Apr; 113(4):537-546. PubMed ID: 33400141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of deferasirox estimated by serum ferritin and labile plasma iron levels in patients with aplastic anemia, myelodysplastic syndrome, or acute myeloid leukemia with transfusional iron overload.
    Kim IH; Moon JH; Lim SN; Sohn SK; Kim HG; Lee GW; Kim YS; Lee HS; Kwon KY; Kim SH; Park KT; Chung JS; Lee WS; Lee SM; Hyun MS; Kim H; Ryoo HM; Bae SH; Joo YD
    Transfusion; 2015 Jul; 55(7):1613-20. PubMed ID: 25764017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Understanding increased ferritin levels in pediatric ECMO patients.
    Weber Z; Sam A; Pena A; Henderson C; McCurnin D; Bhalala U; Garcia R; King J; Carr N
    Blood Cells Mol Dis; 2021 Dec; 92():102617. PubMed ID: 34656943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidentally Detected Transfusion-associated Iron Overload in 3 Children After Cancer Chemotherapy.
    Kuo DJ; Bhagia P
    J Pediatr Hematol Oncol; 2018 Apr; 40(3):e164-e166. PubMed ID: 29300241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longitudinal MRI and Ferritin Monitoring of Iron Overload in Chronically Transfused and Chelated Children With Sickle Cell Anemia and Thalassemia Major.
    Aubart M; Ou P; Elie C; Canniffe C; Kutty S; Delos V; Graffigne C; de Montalembert M; Brousse V
    J Pediatr Hematol Oncol; 2016 Oct; 38(7):497-502. PubMed ID: 27548334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Iron overload in sickle cell anemia : a study of 94 patients].
    Hafsia R; Belakhal F; Ben Salah N; Gouider E; Elborgi W
    Tunis Med; 2011 Jun; 89(6):548-52. PubMed ID: 21681718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Iron overload in hematopoietic cell transplantation.
    Majhail NS; Lazarus HM; Burns LJ
    Bone Marrow Transplant; 2008 Jun; 41(12):997-1003. PubMed ID: 18438425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Burden of iron overload among non-chronically blood transfused preschool children with sickle cell anaemia.
    Olufemi AS; Folashade AA; Adetutu OT
    Afr Health Sci; 2021 Jun; 21(2):753-758. PubMed ID: 34795732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evolution of iron overload in patients with low-risk myelodysplastic syndrome: iron chelation therapy and organ complications.
    Remacha ÁF; Arrizabalaga B; Villegas A; Durán MS; Hermosín L; de Paz R; Garcia M; Diez Campelo M; Sanz G;
    Ann Hematol; 2015 May; 94(5):779-87. PubMed ID: 25516455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Consequences and management of iron overload in sickle cell disease.
    Porter J; Garbowski M
    Hematology Am Soc Hematol Educ Program; 2013; 2013():447-56. PubMed ID: 24319218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autografting as a risk factor for persisting iron overload in long-term survivors of acute myeloid leukaemia.
    Butt NM; Clark RE
    Bone Marrow Transplant; 2003 Nov; 32(9):909-13. PubMed ID: 14561992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High prevalence of iron overload in adult allogeneic hematopoietic cell transplant survivors.
    Majhail NS; DeFor T; Lazarus HM; Burns LJ
    Biol Blood Marrow Transplant; 2008 Jul; 14(7):790-4. PubMed ID: 18541198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of liver and cardiac iron overload using MRI in patients with chronic anemias in Latin American countries: results from ASIMILA study.
    Cancado R; Watman NP; Lobo C; Chona Z; Manzur F; Traina F; Park M; Drelichman G; Zarate JP; Marfil L
    Hematology; 2018 Oct; 23(9):676-682. PubMed ID: 29663858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ferritin trends do not predict changes in total body iron in patients with transfusional iron overload.
    Puliyel M; Sposto R; Berdoukas VA; Hofstra TC; Nord A; Carson S; Wood J; Coates TD
    Am J Hematol; 2014 Apr; 89(4):391-4. PubMed ID: 24347294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of iron overload and iron-chelating therapy on allogeneic hematopoietic SCT in children.
    Lee JW; Kang HJ; Kim EK; Kim H; Shin HY; Ahn HS
    Bone Marrow Transplant; 2009 Dec; 44(12):793-7. PubMed ID: 19398966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Results from a 1-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral Deferasirox in patients diagnosed with low and int-1 risk myelodysplastic syndrome (MDS) and transfusion-dependent iron overload.
    Nolte F; Höchsmann B; Giagounidis A; Lübbert M; Platzbecker U; Haase D; Lück A; Gattermann N; Taupitz M; Baier M; Leismann O; Junkes A; Schumann C; Hofmann WK; Schrezenmeier H
    Ann Hematol; 2013 Jan; 92(2):191-8. PubMed ID: 23073603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study of gonadal hormones in Egyptian female children with sickle cell anemia in correlation with iron overload: Single center study.
    Hagag AA; El-Farargy MS; Elrefaey S; Abo El-enein AM
    Hematol Oncol Stem Cell Ther; 2016 Mar; 9(1):1-7. PubMed ID: 26684919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatic iron overload in children with sickle cell anemia on chronic transfusion therapy.
    Brown K; Subramony C; May W; Megason G; Liu H; Bishop P; Walker T; Nowicki MJ
    J Pediatr Hematol Oncol; 2009 May; 31(5):309-12. PubMed ID: 19415007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi-center study of iron overload.
    Fung EB; Harmatz P; Milet M; Ballas SK; De Castro L; Hagar W; Owen W; Olivieri N; Smith-Whitley K; Darbari D; Wang W; Vichinsky E;
    Am J Hematol; 2007 Apr; 82(4):255-65. PubMed ID: 17094096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and risk factors of iron overload after hematopoietic stem cell transplantation for childhood acute leukemia: a LEA study.
    Sirvent A; Auquier P; Oudin C; Bertrand Y; Bohrer S; Chastagner P; Poirée M; Kanold J; Thouvenin S; Perel Y; Plantaz D; Tabone MD; Yakouben K; Gandemer V; Lutz P; Sirvent N; Vercasson C; Berbis J; Chambost H; Leverger G; Baruchel A; Michel G
    Bone Marrow Transplant; 2017 Jan; 52(1):80-87. PubMed ID: 27595286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.